2023-06-05 20:15:52
Removal of the uterus is a safe option that can save women with cervical cancer, according to a new study shared by the CHU de Québec.
“An international Phase 3 clinical trial led by the Canadian Cancer Trials Group (CCTG), in collaboration with the Gynecological Cancer InterGroup (GCIG), has determined that a simple hysterectomy with pelvic lymph node evaluation is a safe treatment option for women with cervical cancer at an early stage”, summed up the CHU, specifying that the risks were low.
The CHU clarified that simple hysterectomy involves removing the uterus and cervix, while radical hysterectomy also involves removing tissue surrounding the uterus and 1 to 2 cm of vagina.
A total of 700 patients from 12 countries participated in the research. The study looked at the three-year pelvic recurrence rate in patients receiving both types of hysterectomy. The group that underwent a simple hysterectomy had fewer immediate and long-term bladder problems, in addition to having a better quality of life.
“About 44% of women with cervical cancer are diagnosed with the disease at an early stage, a significant proportion of which will meet the criteria for low-risk cancer, according to the study authors. When detected at an early stage, the five-year relative survival rate for invasive cervical cancer is 92%.
“New standard of treatment”
The results were presented by the head of the study, Marie Plante, gynecologist oncologist at the CHU de Québec-Université Laval, on June 2, at the 2023 annual meeting of the American Society of Clinical Oncology (ASCO). The main interested party is delighted that simple hysterectomy is a safe option for women.
“This trial is likely to influence practice, offering a new standard of treatment that is more appropriate for patients with low-risk disease,” she said.
The CHU recalled that cancer of the cervix is the fourth most diagnosed cancer worldwide. It is the fourth most common cause of cancer death in women.
1686058681
#Simple #removal #uterus #solution #cervical #cancer
